- Previous Rank86
- Revenues ($M)36,046
- Revenue Percent Change-1.2%
- Profits ($M)3,625
- Profits Percent Change-25.2%
- Market Value (as of March 31, 2015)64,710
CEO Ellen Kullman has been a target of criticism in the past year by billionaire activist investor Nelson Peltz, who claims the company has a bloated cost structure and could be more profitable if it were broken up. This despite being a healthy investment for DuPont’s shareholders, who have seen gains of 266% over the past six years. In May, Kullman fended off a public fight and attempt by Peltz to grab four board seats by waging an unsuccessful proxy fight. Kullman posits that DuPont will be more a stronger, more profitable company as a diversified conglomerate. The company is currently going through a spinoff of its chemical performance business as they attempt to show growth once again after earnings that been flat over the last few years.
Company Info
| CEO | Edward Breen |
| Industry | Chemicals |
| Sector | Chemicals |
| HQ Location | Wilmington, DE |
| Website | http://www.dupont.com |
| Years on List | 21 |
Key Financials (last fiscal year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | 36,046 | -1.2% |
| Profits ($M) | 3,625 | -25.2% |
| Total Stockholder Equity | 13,320 | - |
| Employees | 63,000 | - |
| Market Value (as of March 31, 2015) | 64,710 | - |
Profit Ratios
| Profit as % of Revenues | 10.1% |
| Profits as % of Assets | 7.3% |
| Profits as % of Stockholder Equity | 27.2% |
Earnings Per Share (last fiscal year)
| Earnings Per Share ($) | 3.92 |
| EPS % Change (from 2013) | -24.3% |
| EPS % Change (5 year annual rate) | 15.3% |
| EPS % Change (10 year annual rate) | 8.3% |
Total Return
| Total Return to Investors (2014) | 17% |
| Total Return to Investors (5 year, annualized) | 21.1% |
| Total Return to Investors (10 year, annualized) | 8.1% |
